Balasubramanian Dorairajan
Direktor/Vorstandsmitglied bei Bharat Biotech International Ltd.
Profil
Balasubramanian Dorairajan is currently a Director at Bharat Biotech International Ltd.
He was previously an Independent Non-Executive Director at Vimta Labs Ltd.
from 2004 to 2019.
He also held a Director position at the Center for Cellular & Molecular Biology.
Dorairajan earned a doctorate degree from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Balasubramanian Dorairajan
| Unternehmen | Position | Beginn |
|---|---|---|
Bharat Biotech International Ltd.
 Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Direktor/Vorstandsmitglied | 31.03.2015 |
Ehemalige bekannte Positionen von Balasubramanian Dorairajan
| Unternehmen | Position | Ende |
|---|---|---|
| VIMTA LABS LIMITED | Direktor/Vorstandsmitglied | 31.03.2019 |
| Center for Cellular & Molecular Biology | Direktor/Vorstandsmitglied | - |
Ausbildung von Balasubramanian Dorairajan
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIMTA LABS LIMITED | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Bharat Biotech International Ltd.
Bharat Biotech International Ltd. BiotechnologyHealth Technology Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India.. | Health Technology |